Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07868510Not yet recruiting
Randomised trial (2 arms), sponsored by Kolosis BIO. Primary endpoint: Rate of successful fusion at 1 year. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07868510.